Analysis of the stromal cell-derived factor 1-3′ A gene polymorphism in pancreatic cancer

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 693-698

  Theodoropoulos, George E ^a   Panoussopoulos, George S ^a   Michalopoulos, Nikolaos V ^a   Zambirinis, Constantinos P ^a   Taka, Stiliani ^b   Stamopoulos, Paraskevas ^a   Gazouli, Maria ^b   Zografos, G ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

CXCL12; Pancreatic cancer; Polymorphisms; Stromal cell derived factor 1

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 77956664057     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000319     Document Type: Article

References (50)

1. Evans DB, Lee JE, Pisters PW, et al: Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. Cancer Treat Res 90: 109-125, 1997.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
3. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
4. Vitone LJ, Greenhalf W, McFaul CD, Ghaneh P and Neoptolemos JP: The inherited genetics of pancreatic cancer and prospects for secondary screening. Best Pract Res Clin Gastroenterol 20: 253-283, 2006.
5. Bartsch H, Malaveille C, Lowenfels AB, Maisonneuve P, Hautefeuille A and Boyle P: Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P) H: quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. Eur J Cancer Prev 7: 215-223, 1998. (Pubitemid 28318342)
6. Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK and Kelsey KT: A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 94: 297-306, 2002. (Pubitemid 34196324)
7. Ockenga J, Vogel A, Teich N, Keim V, Manns MP and Strassburg CP: UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124: 1802-1808, 2003.
8. Mellado M, Rodriguez-Frade JM, Manes S and Martinez AC: Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19: 397-421, 2001. (Pubitemid 32368041)
9. Payne AS and Cornelius LA: The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 118: 915-922, 2002. (Pubitemid 34639168)
10. Rossi D and Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242, 2000.
11. Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445, 1998.
12. Ganju RK, Brubaker SA, Meyer J, et al: The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273: 23169-23175, 1998. (Pubitemid 28417500)
13. Murdoch C and Finn A: Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043, 2000. (Pubitemid 30321151)
14. Mebius RE: Organogenesis of lymphoid tissues. Nat Rev Immunol 3: 292-303, 2003.
15. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T and Honjo T: Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261: 600-603, 1993. (Pubitemid 23278369)
16. Nagasawa T, Kikutani H and Kishimoto T: Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 91: 2305-2309, 1994. (Pubitemid 24092092)
17. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A and Springer TA: A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184: 1101-1109, 1996.
18. Nagasawa T, Hirota S, Tachibana K, et al: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635-638, 1996. (Pubitemid 26268957)
19. Bleul CC, Farzan M, Choe H, et al: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829-833, 1996.
20. Tachibana K, Hirota S, Iizasa H, et al: The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591-594, 1998.
21. Balabanian K, Lagane B, Infantino S, et al: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760-35766, 2005.
22. Schimanski CC, Schwald S, Simiantonaki N, et al: Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11: 1743-1750, 2005.
23. Kato M, Kitayama J, Kazama S and Nagawa H: Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5: R144-R150, 2003.
24. Uchida D, Begum NM, Almofti A, et al: Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 290: 289-302, 2003.
25. Chen Y, Stamatoyannopoulos G and Song CZ: Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 63: 4801-4804, 2003.
26. Mori T, Doi R, Koizumi M, et al: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 3: 29-37, 2004.
27. Koshiba T, Hosotani R, Miyamoto Y, et al: Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6: 3530-3535, 2000.
28. Marchesi F, Monti P, Leone BE, et al: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64: 8420-8427, 2004.
29. Wehler T, Wolfert F, Schimanski CC, et al: Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease. Oncol Rep 16: 1159-1164, 2006.
30. Watanabe MA, de Oliveira Cavassin GG, Orellana MD, et al: SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 35:31-34, 2003.
31. Dean M, Carrington M and O'Brien SJ: Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 3: 263-292, 2002.
32. Voevodin A, Samilchuk E and Dashti S: Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis. J Med Virol 58: 54-58, 1999.
33. Winkler C, Modi W, Smith MW, et al: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279: 389-393, 1998.
34. Sei S, O'Neill DP, Stewart SK, et al: Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma. Cancer Res 61: 5028-5037, 2001.
35. Ide A, Kawasaki E, Abiru N, et al: Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population. Hum Immunol 64: 973-978, 2003.
36. Hassan S, Baccarelli A, Salvucci O and Basik M: Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 14: 446-454, 2008.
37. Khademi B, Razmkhah M, Erfani N, Gharagozloo M and Ghaderi A: SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathol Oncol Res 14: 45-50, 2008.
38. Hirata H, Hinoda Y, Kikuno N, et al: CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res 13: 5056-5062, 2007.
39. Nahon P, Sutton A, Rufat P, et al: Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. World J Gastroenterol 14: 713-719, 2008.
40. Razmkhah M, Doroudchi M, Ghayumi SM, Erfani N and Ghaderi A: Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 49: 311-315, 2005.
41. Coelho A, Calcada C, Catarino R, Pinto D, Fonseca G and Medeiros R: CXCL12-3′ A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy? Cancer Immunol Immunother 55: 639-643, 2006.
42. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T and Ghaderi A: Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 225: 261-266, 2005. (Pubitemid 40835873)
43. Dimberg J, Hugander A, Lofgren S and Wagsater D: Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med 19: 11-15, 2007.
44. Hidalgo-Pascual M, Galan JJ, Chaves-Conde M, et al: Analysis of CXCL12 3′UTR G>A polymorphism in colorectal cancer. Oncol Rep 18: 1583-1587, 2007.
45. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S and Tosato G: Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99: 2703-2711, 2002.
46. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
47. Petit I, Szyper-Kravitz M, Nagler A, et al: G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3: 687-94, 2002
48. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP and Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686, 2003.
49. Burger M, Glodek A, Hartmann T, et al: Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22: 8093-8101, 2003.
50. Cardones AR, Murakami T and Hwang ST: CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res 63: 6751-6757, 2003.